ArticleCancer chemotherapy and pharmacology2022

Adaptation of lenvatinib treatment in patients with hepatocellular carcinoma and portal vein tumor thrombosis.

Takanori Mukozu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.